Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 Fatty Acids for Sinus Rhythm Maintenance After AF Ablation
NCT00791089Phase 4Terminated
- Sponsor
- University of Michigan
- Start
- Nov 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of eicosapentaenoic acid + docosahexaenoic acid in Atrial fibrillation (AFib), sponsored by University of Michigan. Started Nov 2008; status: terminated.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00791089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00791089.